Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis

Table 2 Post-operative data and complications after resection in the study population

	mean ± SD/ n (%)
Serum bilirubin (mg/dL)	1.5 ± 0.64
AST (U/L)	29.95 ± 11.31
ALT (U/L)	20.51 ± 10.03
Serum albumin (g/dL)	3.21 ± 0.41
INR	1.25 ± 0.14
Serum Creatinin (mg/dL)	0.87 ± 0.23
Serum AFP (ng/mL)	2109.7 ± 10795.17
CRP (mg/L)	45.99 ± 31.19
Length of the hospital stay (d)	8.9 ± 5.05
ICU stay (d)	4.28 ± 4.19
Child-Pugh score
On discharge	6.62 ± 1.54
3-mo post-operative	6.51 ± 1.1
MELD score	10.63 ± 2.27
ICU stay, n (%)	58 (48.3)
MELD score, n (%)
≤ 10	68 (56.7)
> 10	52 (43.3)
50-50 criteria, n (%)
Absent	116 (96.7)
Present	4 (3.3)
PHLF, n (%)
Absent	76 (63.3)
Grade A	16 (13.3)
Grade B	22 (18.3)
Grade C	6 (5)
Post-operative complications, n (%)
Hemorrhage	4 (3.3)
Bile leak	2 (1.7)
Wound infection	4 (3.3)
Chest infection	14 (11.7)
Recurrence of HCC, n (%)	34 (28.3)
Post-operative decompensation, n (%)	50 (41.7)
Peri-operative mortality, n (%)	4 (3.3)
Overall survival, n (%)
Alive	70 (58.3)
Died	50 (41.7)

HCC: Hepatocellular carcinoma; MELD: Model for end-stage liver disease; PHLF: Post-hepatectomy liver failure; ICU: Intensive care units; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; INR: International normalized ratio; CRP: C-reactive protein.